Skip to main content
Newsletters
Axios Local
Show
Axios Pro
Axios Live
The Axios Show
Login
Axios
All topics
Axios
Search
Back to Business
Dealmaking
All stories
Business
Oct 2, 2026
Novartis signs $7.8 billion drug deal with Chinese startup
Go deeper (<1 min. read)
Business
Oct 2, 2026
Skydance will be name of combined Paramount-Warner Bros. Discovery
Go deeper (1 min. read)
World
Oct 2, 2026
Why Washington and Tehran keep talking past each other
Go deeper (3 min. read)
Business
Oct 1, 2026
Jake Paul's Anti Fund seeks $400M for new VC fund
Go deeper (<1 min. read)
Business
Oct 1, 2026
Vinod Khosla talks Seahawks, AI and agents
Go deeper (3 min. read)
Business
Oct 1, 2026
Sycamore seeks to break up the Walgreens Boots Alliance
Go deeper (<1 min. read)
Business
Sep 30, 2026
David Ellison names Ynon Kreiz as Paramount-WBD co-CEO
Go deeper (1 min. read)
Business
Sep 30, 2026
Bull and bear case for Anthropic's IPO
Go deeper (2 min. read)
Business
Sep 30, 2026
Investors' P-doom scenario in AI: Lack of profits
Go deeper (2 min. read)
Business
Sep 30, 2026
Why the hot IPO market appears to be cooling
Go deeper (1 min. read)
View more stories
C-Suite
Retail news
Media & journalism industry
Elon Musk
Dealmaking
Back to Business
In Business
C-Suite
Retail news
Media & journalism industry
Elon Musk
Dealmaking
Back to Business
